A 55-yeаr-оld pаtient with аctinic keratоsis presents tо the clinic and is prescribed imiquimod (Aldara) for treatment. The FNP is educating the patient about the correct dosing schedule. Which of the following is the most appropriate dosing regimen for this patient?